Multiple Sclerosis Information (MSi)

On-Demand Videos, Webinars and Webcasts Welcome to MSAA’s new program initiative, Multiple Sclerosis Information (MSi). Through the MSi initiative, MSAA will offer an extensive library of on-demand video programming, webcasts, professionally monitored chat rooms, and additional interactive communication features that bring knowledge and empowerment right into the privacy and comfort of a person’s home. Click […]

Read News Article

FDA Approves First Drug to Treat Two Forms of MS

On March 28, 2017, the United States Food and Drug Administration (FDA) announced the approval of Ocrevus™ (ocrelizumab) for the treatment of two types of multiple sclerosis (MS): relapsing forms of MS (RMS) and primary-progressive MS (PPMS). This is the first time that a medication for MS has been approved for two types of the […]

Read News Article

MSAA Video: Changing Lives Monday to Sunday

Multiple sclerosis never takes a day off. Neither does MSAA’s commitment to making a difference in the lives of people with MS. That is why as part of MS Awareness Month, we are proud to launch our new video, Changing Lives Monday to Sunday. MSAA developed this brief but powerful awareness video to showcase the […]

Read News Article